Literature DB >> 12218650

Serum creatinine levels correlate with plasma amyloid Beta protein.

Zoe Arvanitakis1, John A Lucas, Linda H Younkin, Steven G Younkin, Neill R Graff-Radford.   

Abstract

The authors investigated the effect of renal function on plasma amyloid beta protein (Abeta) by analyzing the relationship between creatinine (Cr) and Abeta40 or Abeta42 in plasma from 59 normal control subjects (NC) and 220 Alzheimer disease (AD) patients. In all 279 subjects, Cr was significantly associated with Abeta40 (p < 0.001) and Abeta42 (p < 0.01), accounting for 7.3% and 3.1% of shared variance, respectively. Significant associations were also present in NC and AD groups separately. These results indicate that it may be useful to consider Cr levels when measuring plasma Abeta.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12218650     DOI: 10.1097/00002093-200207000-00009

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  28 in total

Review 1.  Biomarkers of Alzheimer disease in plasma.

Authors:  Michael C Irizarry
Journal:  NeuroRx       Date:  2004-04

Review 2.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

3.  Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI.

Authors:  Jon B Toledo; Hugo Vanderstichele; Michal Figurski; Paul S Aisen; Ronald C Petersen; Michael W Weiner; Clifford R Jack; William Jagust; Charles Decarli; Arthur W Toga; Estefanía Toledo; Sharon X Xie; Virginia M-Y Lee; John Q Trojanowski; Leslie M Shaw
Journal:  Acta Neuropathol       Date:  2011-07-30       Impact factor: 17.088

4.  Association Between Serum Amyloid-Beta and Renal Functions: Implications for Roles of Kidney in Amyloid-Beta Clearance.

Authors:  Yu-Hui Liu; Yang Xiang; Ye-Ran Wang; Shu-Sheng Jiao; Qing-Hua Wang; Xian-Le Bu; Chi Zhu; Xiu-Qing Yao; Brian Giunta; Jun Tan; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Mol Neurobiol       Date:  2014-08-14       Impact factor: 5.590

5.  Meta-analysis of plasma amyloid-β levels in Alzheimer's disease.

Authors:  Fei Song; Anne Poljak; Michael Valenzuela; Richard Mayeux; George A Smythe; Perminder S Sachdev
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Amyloid-associated depression: a prodromal depression of Alzheimer disease?

Authors:  Xiaoyan Sun; David C Steffens; Rhoda Au; Marshal Folstein; Paul Summergrad; Jacqueline Yee; Irwin Rosenberg; D Mkaya Mwamburi; Wei Qiao Qiu
Journal:  Arch Gen Psychiatry       Date:  2008-05

7.  Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.

Authors:  Victoria Busby; Steven Goossens; Petra Nowotny; Gillian Hamilton; Scott Smemo; Denise Harold; Dragana Turic; Luke Jehu; Amanda Myers; Meredith Womick; Daniel Woo; Danielle Compton; Lisa M Doil; Kristina M Tacey; Kit F Lau; Safa Al-Saraj; Richard Killick; Stuart Pickering-Brown; Pamela Moore; Paul Hollingworth; Nicola Archer; Catherine Foy; Sarah Walter; Corrine Lendon; Takeshi Iwatsubo; John C Morris; Joanne Norton; David Mann; Barbara Janssens; John Hardy; Michael O'Donovan; Lesley Jones; Julie Williams; Peter Holmans; Michael J Owen; Andrew Grupe; John Powell; Jolanda van Hengel; Alison Goate; Frans Van Roy; Simon Lovestone
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

8.  Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.

Authors:  T T Seppälä; S-K Herukka; T Hänninen; S Tervo; M Hallikainen; H Soininen; T Pirttilä
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-05-16       Impact factor: 10.154

9.  High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients.

Authors:  Laila Abdullah; Cheryl Luis; Daniel Paris; Ghania Ait-ghezala; Benoit Mouzon; Elizabeth Allen; Julia Parrish; Myles A Mullan; Scott Ferguson; Marcie Wood; Fiona Crawford; Michael Mullan
Journal:  Mol Med       Date:  2009-12-08       Impact factor: 6.354

10.  Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study.

Authors:  O L Lopez; L H Kuller; P D Mehta; J T Becker; H M Gach; R A Sweet; Y F Chang; R Tracy; S T DeKosky
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.